PRP vs GFC vs Exosome Therapy: A Complete Comparison of Regenerative Orthobiologic Treatments

**KEY FACT**

PRP, GFC, and Exosome therapy are all “regenerative” or “orthobiologic” treatments used to help joints, tendons, and ligaments heal without surgery. But they are not interchangeable, and they don’t have equal scientific backing. PRP and GFC are made from your own blood and have the strongest published clinical evidence in orthopedics — MT Hospital currently offers both, under ultrasound guidance, at our Baneshwor and Dhobighat clinics. Exosome therapy is a newer, donor-cell-derived treatment that MT Hospital is preparing to introduce specifically for joint and orthopedic conditions, as part of our ongoing investment in evidence-based regenerative care. This guide explains what each one actually is, so you can evaluate any clinic’s claims — including ours — with clear eyes.
## Why We’re Writing This

Regenerative medicine is one of the fastest-growing — and most heavily marketed — areas in orthopedic care. As patients research options for knee osteoarthritis, tendon injuries, or sports injuries, they increasingly come across all three terms used almost interchangeably in clinic marketing, even though they are biologically very different and have very different levels of evidence behind them. At MT Hospital, we believe an informed patient makes a better decision, so here is a transparent, evidence-based comparison of all three.

## PRP (Platelet-Rich Plasma)

**Source:** Your own blood (autologous).

**How it’s made:** Blood is drawn and spun in a centrifuge to concentrate the platelets and plasma, leaving behind a solution 3–5 times richer in platelets than normal blood.

**How it works:** The concentrated platelets are injected directly into the injured joint, tendon, or ligament, where they release growth factors gradually as they activate and break down, stimulating the body’s own repair processes.

**Evidence base:** The strongest of the three. PRP has been studied in dozens of randomized controlled trials across knee osteoarthritis, tendon injuries (such as tennis elbow and patellar tendinopathy), and ligament sprains, generally showing meaningful improvement in pain and function compared to placebo, and in several studies, comparable or better outcomes than hyaluronic acid or corticosteroid injections.

**Safety profile:** Excellent — because it comes from your own blood, there is no risk of immune rejection or disease transmission from a donor.

## GFC (Growth Factor Concentrate)

**Source:** Also your own blood (autologous).

**How it’s made:** Similar starting point to PRP, but processed further — platelets are activated and ruptured to release their growth factors, and the cellular material (red cells, white cells, and spent platelets) is filtered out, leaving a concentrated, largely acellular growth factor solution.

**How it works:** The growth factors are delivered directly and immediately to the injury site in concentrated form, with the white-blood-cell component (a driver of post-injection inflammation) removed.

**Evidence base:** Smaller than PRP’s but growing, including placebo-controlled randomized trials in knee osteoarthritis showing sustained pain and function improvement, with some studies also showing reductions in biomarkers associated with cartilage breakdown.

**Safety profile:** Also excellent, for the same reason as PRP — it is derived from your own blood.

## Exosome Therapy

**Source:** Typically derived from donor mesenchymal stem cells or from your own blood, processed and purified in a laboratory.

**How it’s made:** Exosomes are tiny extracellular vesicles — essentially “messenger packets” — released by cells. In commercial exosome products, these are harvested from cultured donor stem cells, purified, and prepared for injection.

**How it works:** Exosomes carry proteins, growth factors, and genetic material (RNA) that signal to your own cells, theoretically influencing inflammation and tissue repair processes more precisely than a simple growth factor dose.

**Evidence base:** This is where exosome therapy differs most sharply from PRP and GFC. As of now, there are no large-scale, high-quality randomized controlled trials demonstrating exosome therapy’s effectiveness for orthopedic conditions such as knee arthritis, tendon injuries, or sports injuries. Major regulators, including the US FDA, have explicitly stated that exosome products are not approved for treating orthopedic conditions. Much of what’s currently available is supported by laboratory and animal studies, early-phase human pilot studies, and considerable marketing — not the level of clinical proof that exists for PRP and, increasingly, GFC.

**Safety considerations:** Because exosome products typically come from a donor source rather than your own body, there are additional considerations around sourcing, processing standards, and regulatory oversight that do not apply to autologous treatments like PRP and GFC. Quality and purity can vary significantly between products and suppliers.

## Side-by-Side Summary

**Where it comes from:** PRP — your own blood. GFC — your own blood, further processed. Exosome — typically donor stem cells, lab-processed.

**What’s injected:** PRP — concentrated platelets. GFC — concentrated growth factors, cell-free. Exosome — purified extracellular vesicles from donor cells.

**Strength of clinical evidence for orthopedic use:** PRP — strong, extensive. GFC — moderate and growing. Exosome — limited; largely pre-clinical and early-stage.

**Regulatory standing for orthopedic indications:** PRP and GFC are autologous, blood-derived treatments used clinically within standard medical practice. Exosome products for orthopedic conditions are not approved by major regulatory bodies and remain investigational.

**Rejection/immune risk:** PRP and GFC — essentially none, since the material is your own. Exosome — depends entirely on the sourcing and processing quality of the donor-derived product.

## Exosome Therapy for Joints — Coming to MT Hospital

MT Hospital currently offers PRP and GFC for joint, tendon, ligament, and sports injury conditions — both autologous (from your own body) and both backed by a credible and growing body of peer-reviewed clinical evidence. We are also actively preparing to introduce exosome therapy specifically for orthopedic and joint conditions as part of our regenerative medicine programme, expanding the toolkit we can offer patients alongside PRP and GFC.

When we launch our exosome programme, it will be held to the same standard as everything else we offer: properly sourced and quality-tested material, clear communication with patients about what the evidence does and doesn’t yet show for their specific condition, and a recommendation based on what’s clinically appropriate for you — not on what sounds the most advanced. In some cases, exosome therapy may be used alongside PRP or GFC; in others, as a primary option, depending on your diagnosis.

Note that exosome therapy is also used in other fields, such as aesthetics and hair restoration — at MT Hospital, our exosome programme is being developed specifically for **orthopedic and joint conditions**, in line with the rest of our regenerative orthopedic services. We’ll update this article as our exosome programme launches and as the clinical evidence base continues to develop.

## Frequently Asked Questions

**Is exosome therapy the “newest and best” option, since it’s the most advanced-sounding?**
Not necessarily. Being newer doesn’t mean better-proven. In medicine, the strength of a treatment is judged by clinical trial evidence, not how advanced it sounds in marketing material. Right now, PRP has the strongest evidence, GFC is building a solid evidence base, and exosome therapy for joints remains less evident in humans.

**Does MT Hospital offer exosome therapy yet?**
Not yet — we currently offer PRP and GFC for joint, tendon, and sports injury conditions. Our exosome programme, specifically for orthopedic and joint use, is in preparation. If you’re interested, ask our team for the latest update when you book a consultation.

**What should I ask before getting exosome therapy anywhere?**
Because exosome products are donor-derived and less standardized than autologous treatments like PRP and GFC, it’s reasonable to ask any clinic — including ours, once our programme launches — where the exosomes are sourced from, what quality and safety testing the product undergoes, and what evidence supports its use for your specific condition. A clinic that answers these clearly is one worth trusting.

**Can PRP and GFC be combined?**
In some cases, yes — your treating physician can advise whether a combined or sequential approach suits your specific condition.

**Which should I choose, PRP or GFC?**
This depends on your specific diagnosis, joint, and treatment history. See our dedicated comparison article, “GFC vs PRP for Knee and Joint Pain,” for a detailed breakdown, or book a consultation with our team for a personalised recommendation.

## Get an Honest, Evidence-Based Recommendation

At MT Hospital — Nepal’s pioneer in manual therapy since 2011 — our priority is recommending what the evidence actually supports for your condition, not whichever treatment sounds the most advanced. If you’re considering regenerative therapy for a joint, tendon, or sports injury, book a consultation at our Baneshwor or Dhobighat clinic and we’ll walk you through your real options, honestly.

*This article is for general information only and reflects the current published evidence as of 2026. It is not a substitute for individual medical assessment. Regenerative medicine research is an evolving field, and recommendations may be updated as new evidence emerges.*